Table 1 MMR patients details Patient no.... | American Society of Hematology

Table 1

MMR patients details

Patient no.	Sex, age, y	Euro risk score	Dose of imatinib/d, mg	Y from diagnosis	Y on imatinib	Molecular response at the time of sorting (BCR-ABL^IS), %	Most recent molecular response (BCR-ABL^IS), %
1	F, 59	Low	400	1*	1	0	0
		831		2.3†	2.3
2	F, 39	Low	800-400	2†	2	0.033	0.017
		614		3*	3	0.0097
				4†	4	0.019
3	M, 73	Interm	400	3	3	0	0
		911		4*†	4
4	M, 57	Interm	400 + IFN	4*	4	0.019	0.0076
		1313
5	M, 57	Interm	400	2.4*†	2.4	0.025	0.011
		1118.3
6	M, 71	Interm	800-400	0.10*	0.10	0	0
		870.5		1.10†	1.10	0	0
7	M, 31	Interm	400	1*	1	0.26	0.068
		1098.1
8	F, 59	Unknown	400	2.1*	2.1	0	0
9	M, 58	Interm	800	2.7*	2.7	0.0025	0.023
		1438
10	F, 41	Low	400	1.9†	1.9	0.014
		445.3		3*	3	0.064	0.031
				4†	4	0.031
11	F, 80	1083	400	1*	1	CCyR
		Interm
12	M, 53	Interm	400	1.7	1.7	0.24	0.034
		1432		2.7*†	2.7	0.041
				3.8†	3.8	0.034
13	M, 38	Low	400	6.3	5.6	0.047	0.041
		369.1
14	M, 56	Unknown	400	7.4	7.4	0	0
15	M, 27	Low	400	4.9	4.9	0	0
		245.2
16	F, 40	Low	800-400	1†	1	0.012	0.0085
		699.5		2.10†	2.10	0.0085
17	F, 64	Interm	800-400	2.3	2.3	0.025	0.0097
		994.4
18	F, 73	Interm	400	4.5†	4.3	0.049	0.019
		1443.7
19	M, 67	Low	800	4.5†	4.5	0.012	0.027
		749

Patient no.	Sex, age, y	Euro risk score	Dose of imatinib/d, mg	Y from diagnosis	Y on imatinib	Molecular response at the time of sorting (BCR-ABL^IS), %	Most recent molecular response (BCR-ABL^IS), %
1	F, 59	Low	400	1*	1	0	0
		831		2.3†	2.3
2	F, 39	Low	800-400	2†	2	0.033	0.017
		614		3*	3	0.0097
				4†	4	0.019
3	M, 73	Interm	400	3	3	0	0
		911		4*†	4
4	M, 57	Interm	400 + IFN	4*	4	0.019	0.0076
		1313
5	M, 57	Interm	400	2.4*†	2.4	0.025	0.011
		1118.3
6	M, 71	Interm	800-400	0.10*	0.10	0	0
		870.5		1.10†	1.10	0	0
7	M, 31	Interm	400	1*	1	0.26	0.068
		1098.1
8	F, 59	Unknown	400	2.1*	2.1	0	0
9	M, 58	Interm	800	2.7*	2.7	0.0025	0.023
		1438
10	F, 41	Low	400	1.9†	1.9	0.014
		445.3		3*	3	0.064	0.031
				4†	4	0.031
11	F, 80	1083	400	1*	1	CCyR
		Interm
12	M, 53	Interm	400	1.7	1.7	0.24	0.034
		1432		2.7*†	2.7	0.041
				3.8†	3.8	0.034
13	M, 38	Low	400	6.3	5.6	0.047	0.041
		369.1
14	M, 56	Unknown	400	7.4	7.4	0	0
15	M, 27	Low	400	4.9	4.9	0	0
		245.2
16	F, 40	Low	800-400	1†	1	0.012	0.0085
		699.5		2.10†	2.10	0.0085
17	F, 64	Interm	800-400	2.3	2.3	0.025	0.0097
		994.4
18	F, 73	Interm	400	4.5†	4.3	0.049	0.019
		1443.7
19	M, 67	Low	800	4.5†	4.5	0.012	0.027
		749

F indicates female; M, male; y, years; IS, international scale; and intern, intermediate.

Analysis of BCR-ABL expression in individual CFUs.

Analysis of BCR-ABL expression in total sorted bone marrow subfractions.